Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Spark Therap (ONCE)

Spark Therap (ONCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,375,056
  • Shares Outstanding, K 38,523
  • Annual Sales, $ 64,730 K
  • Annual Income, $ -78,820 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 2.05
  • Price/Sales 65.92
  • Price/Cash Flow N/A
  • Price/Book 12.63
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -6.56
  • Most Recent Earnings $-1.67 on 02/19/19
  • Next Earnings Date 11/26/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -1.47
  • Number of Estimates 3
  • High Estimate -1.13
  • Low Estimate -1.84
  • Prior Year -1.75
  • Growth Rate Est. (year over year) +16.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
109.25 +0.73%
on 12/04/19
113.90 -3.38%
on 12/16/19
-0.76 (-0.69%)
since 11/15/19
3-Month
95.92 +14.73%
on 10/02/19
113.90 -3.38%
on 12/16/19
+5.65 (+5.41%)
since 09/17/19
52-Week
34.53 +218.71%
on 12/26/18
114.20 -3.63%
on 03/12/19
+69.70 (+172.74%)
since 12/17/18

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Spark Therapeutics, Inc. offers gene therapy. The Company's product candidate consist of SPK-RPE65, SPK-CHM, SPK-FIX which are in different clinical phases, for the treatment of additional blinding conditions, hematologic disorders and neurodegenerative diseases. Spark Therapeutics, Inc. is based in...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 114.08
1st Resistance Point 113.82
Last Price 113.57
1st Support Level 113.39
2nd Support Level 113.22
3rd Support Level N/A

See More

52-Week High 114.20
Last Price 113.57
Fibonacci 61.8% 83.77
Fibonacci 50% 74.36
Fibonacci 38.2% 64.96
52-Week Low 34.53

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar